The first medication for obstructivesleepapnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ...
Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructivesleepapnea (OSA) in adults with obesity. Studies have shown that when ...
Some results have been hidden because they may be inaccessible to you